• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成对CRISPR-Cas切口酶在原代人类细胞中的靶向和脱靶效应。

On- and off-target effects of paired CRISPR-Cas nickase in primary human cells.

作者信息

Klermund Julia, Rhiel Manuel, Kocher Thomas, Chmielewski Kay Ole, Bischof Johannes, Andrieux Geoffroy, El Gaz Melina, Hainzl Stefan, Boerries Melanie, Cornu Tatjana I, Koller Ulrich, Cathomen Toni

机构信息

Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg, 79106 Freiburg, Germany; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, 79106 Freiburg, Germany.

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

出版信息

Mol Ther. 2024 May 1;32(5):1298-1310. doi: 10.1016/j.ymthe.2024.03.006. Epub 2024 Mar 7.

DOI:10.1016/j.ymthe.2024.03.006
PMID:38459694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11081867/
Abstract

Undesired on- and off-target effects of CRISPR-Cas nucleases remain a challenge in genome editing. While the use of Cas9 nickases has been shown to minimize off-target mutagenesis, their use in therapeutic genome editing has been hampered by a lack of efficacy. To overcome this limitation, we and others have developed double-nickase-based strategies to generate staggered DNA double-strand breaks to mediate gene disruption or gene correction with high efficiency. However, the impact of paired single-strand nicks on genome integrity has remained largely unexplored. Here, we developed a novel CAST-seq pipeline, dual CAST, to characterize chromosomal aberrations induced by paired CRISPR-Cas9 nickases at three different loci in primary keratinocytes derived from patients with epidermolysis bullosa. While targeting COL7A1, COL17A1, or LAMA3 with Cas9 nucleases caused previously undescribed chromosomal rearrangements, no chromosomal translocations were detected following paired-nickase editing. While the double-nicking strategy induced large deletions/inversions within a 10 kb region surrounding the target sites at all three loci, similar to the nucleases, the chromosomal on-target aberrations were qualitatively different and included a high proportion of insertions. Taken together, our data indicate that double-nickase approaches combine efficient editing with greatly reduced off-target effects but still leave substantial chromosomal aberrations at on-target sites.

摘要

CRISPR-Cas核酸酶产生的意外的靶向和脱靶效应仍然是基因组编辑中的一个挑战。虽然使用Cas9切口酶已被证明可将脱靶诱变降至最低,但它们在治疗性基因组编辑中的应用因缺乏有效性而受到阻碍。为了克服这一限制,我们和其他人开发了基于双切口酶的策略,以产生交错的DNA双链断裂,从而高效介导基因破坏或基因校正。然而,配对单链切口对基因组完整性的影响在很大程度上仍未得到探索。在这里,我们开发了一种新颖的CAST-seq流程,即双重CAST,以表征由配对的CRISPR-Cas9切口酶在源自大疱性表皮松解症患者的原代角质形成细胞的三个不同位点诱导的染色体畸变。虽然用Cas9核酸酶靶向COL7A1、COL17A1或LAMA3会导致先前未描述的染色体重排,但在配对切口酶编辑后未检测到染色体易位。虽然双切口策略在所有三个位点的靶位点周围10 kb区域内诱导了大片段缺失/倒位,类似于核酸酶,但染色体上的靶向畸变在性质上有所不同,并且包括高比例的插入。综上所述,我们的数据表明,双切口酶方法将高效编辑与大大降低的脱靶效应相结合,但仍会在靶位点留下大量染色体畸变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/11081867/c600d44134b6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/11081867/4033093b1489/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/11081867/17904f197af0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/11081867/669a2e44d0e3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/11081867/189797de2ca7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/11081867/c600d44134b6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/11081867/4033093b1489/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/11081867/17904f197af0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/11081867/669a2e44d0e3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/11081867/189797de2ca7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/11081867/c600d44134b6/gr4.jpg

相似文献

1
On- and off-target effects of paired CRISPR-Cas nickase in primary human cells.成对CRISPR-Cas切口酶在原代人类细胞中的靶向和脱靶效应。
Mol Ther. 2024 May 1;32(5):1298-1310. doi: 10.1016/j.ymthe.2024.03.006. Epub 2024 Mar 7.
2
Efficient genome editing by FACS enrichment of paired D10A Cas9 nickases coupled with fluorescent proteins.通过 FACS 富集配对 D10A Cas9 切口酶与荧光蛋白对基因组进行高效编辑。
Arch Pharm Res. 2018 Sep;41(9):911-920. doi: 10.1007/s12272-018-1042-2. Epub 2018 May 31.
3
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.COL7A1 通过 CRISPR/Cas9 在隐性营养不良性大疱性表皮松解症中的编辑。
Mol Ther. 2017 Nov 1;25(11):2573-2584. doi: 10.1016/j.ymthe.2017.07.005. Epub 2017 Jul 13.
4
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases.CRISPR/Cas 衍生的 RNA 引导内切酶和 Nickase 的脱靶效应分析。
Genome Res. 2014 Jan;24(1):132-41. doi: 10.1101/gr.162339.113. Epub 2013 Nov 19.
5
Utilization of nicking properties of CRISPR-Cas12a effector for genome editing.利用 CRISPR-Cas12a 效应物的切口特性进行基因组编辑。
Sci Rep. 2024 Feb 9;14(1):3352. doi: 10.1038/s41598-024-53648-2.
6
Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA.多重串联的猴免疫缺陷病毒特异性 RNA 引导的 Cas9 切口酶使前病毒 DNA 失活。
J Virol. 2021 Nov 9;95(23):e0088221. doi: 10.1128/JVI.00882-21. Epub 2021 Sep 22.
7
Expanding the editable genome and CRISPR-Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking.利用基于转座体配对缺口的无 DNA 切割基因靶向技术扩展可编辑基因组和 CRISPR-Cas9 的多功能性。
Nucleic Acids Res. 2020 Jan 24;48(2):974-995. doi: 10.1093/nar/gkz1121.
8
Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases.剪接与粘贴:利用 CRISPR/Cas9 核酸酶实现显性负性 KRT14 突变的高效同源定向修复。
Mol Ther. 2017 Nov 1;25(11):2585-2598. doi: 10.1016/j.ymthe.2017.08.015. Epub 2017 Aug 24.
9
Precision Targeted Mutagenesis via Cas9 Paired Nickases in Rice.利用Cas9双切口酶在水稻中进行精准靶向诱变
Plant Cell Physiol. 2016 May;57(5):1058-68. doi: 10.1093/pcp/pcw049. Epub 2016 Mar 2.
10
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1.高效、安全的 Cas9 内切酶-尼克酰胺酶对 1 型原发性高草酸尿症的治疗作用。
EMBO Mol Med. 2024 Jan;16(1):112-131. doi: 10.1038/s44321-023-00008-8. Epub 2024 Jan 5.

引用本文的文献

1
The Interface of Gene Editing with Regenerative Medicine.基因编辑与再生医学的界面
Engineering (Beijing). 2025 Mar;46:73-100. doi: 10.1016/j.eng.2024.10.019. Epub 2024 Nov 30.
2
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease.靶向基因编辑以及CYBA和CYBB的近乎普遍的cDNA插入作为慢性肉芽肿病的一种治疗方法。
Nat Commun. 2025 Aug 12;16(1):7475. doi: 10.1038/s41467-025-62738-2.
3
Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges.

本文引用的文献

1
Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing.同时抑制 DNA-PK 和 Polϴ 可提高基因组编辑的整合效率和精度。
Nat Commun. 2023 Aug 14;14(1):4761. doi: 10.1038/s41467-023-40344-4.
2
Strategies for precise gene edits in mammalian cells.哺乳动物细胞中精确基因编辑的策略。
Mol Ther Nucleic Acids. 2023 Apr 19;32:536-552. doi: 10.1016/j.omtn.2023.04.012. eCollection 2023 Jun 13.
3
T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds.
用于人类治疗的CRISPR-Cas基因组编辑中的脱靶效应:进展与挑战。
Mol Ther Nucleic Acids. 2025 Jul 17;36(3):102636. doi: 10.1016/j.omtn.2025.102636. eCollection 2025 Sep 9.
4
The hidden risks of CRISPR/Cas: structural variations and genome integrity.CRISPR/Cas的潜在风险:结构变异与基因组完整性
Nat Commun. 2025 Aug 5;16(1):7208. doi: 10.1038/s41467-025-62606-z.
5
A bioinformatic analysis of gene editing off-target loci altered by common polymorphisms, using 'PopOff'.使用“PopOff”对由常见多态性改变的基因编辑脱靶位点进行生物信息学分析。
J R Soc N Z. 2024 May 9;55(6):2440-2463. doi: 10.1080/03036758.2024.2347968. eCollection 2025.
6
Enhancing Specificity, Precision, Accessibility, Flexibility, and Safety to Overcome Traditional CRISPR/Cas Editing Challenges and Shape Future Innovations.增强特异性、精准性、可及性、灵活性和安全性,以克服传统CRISPR/Cas编辑挑战并塑造未来创新。
Adv Sci (Weinh). 2025 Jul;12(28):e2416331. doi: 10.1002/advs.202416331. Epub 2025 Jun 23.
7
Deep Learning Based Models for CRISPR/Cas Off-Target Prediction.基于深度学习的CRISPR/Cas脱靶预测模型
Small Methods. 2025 Jul;9(7):e2500122. doi: 10.1002/smtd.202500122. Epub 2025 Jun 4.
8
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cells.衰老和炎症是CRISPR-Cas9/AAV6介导的造血干细胞基因编辑产生的意外不良后果。
Cell Rep Med. 2025 Jun 17;6(6):102157. doi: 10.1016/j.xcrm.2025.102157. Epub 2025 Jun 3.
9
Application of CRISPR/Cas gene editing for infectious disease control in poultry.CRISPR/Cas基因编辑在禽类传染病防控中的应用。
Open Life Sci. 2025 May 20;20(1):20251095. doi: 10.1515/biol-2025-1095. eCollection 2025.
10
Optimization of hypo-alloimmunogenic multispecific CAR-T and SARS-CoV-2-specific T cells for off-the-shelf adoptive cell therapy.用于现成过继性细胞疗法的低同种异体免疫原性多特异性嵌合抗原受体T细胞和严重急性呼吸综合征冠状病毒2特异性T细胞的优化
Mol Ther Methods Clin Dev. 2025 Apr 10;33(2):101462. doi: 10.1016/j.omtm.2025.101462. eCollection 2025 Jun 12.
T-CAST:一种用于TALEN的优化CAST-Seq流程证实了专一性异二聚体支架具有更高的安全性和有效性。
Front Genome Ed. 2023 Feb 20;5:1130736. doi: 10.3389/fgeed.2023.1130736. eCollection 2023.
4
Modulating mutational outcomes and improving precise gene editing at CRISPR-Cas9-induced breaks by chemical inhibition of end-joining pathways.通过化学抑制末端连接途径来调节 CRISPR-Cas9 诱导断裂处的突变结果和提高精确基因编辑。
Cell Rep. 2023 Feb 28;42(2):112019. doi: 10.1016/j.celrep.2023.112019. Epub 2023 Jan 25.
5
Clinical genome editing to treat sickle cell disease-A brief update.用于治疗镰状细胞病的临床基因组编辑——简要更新
Front Med (Lausanne). 2023 Jan 9;9:1065377. doi: 10.3389/fmed.2022.1065377. eCollection 2022.
6
Human genetic diversity alters off-target outcomes of therapeutic gene editing.人类遗传多样性改变了治疗性基因编辑的脱靶效应。
Nat Genet. 2023 Jan;55(1):34-43. doi: 10.1038/s41588-022-01257-y. Epub 2022 Dec 15.
7
editing homology-directed repair in junctional epidermolysis bullosa.编辑交界性大疱性表皮松解症中的同源定向修复
Front Med (Lausanne). 2022 Aug 25;9:976604. doi: 10.3389/fmed.2022.976604. eCollection 2022.
8
SIQ: easy quantitative measurement of mutation profiles in sequencing data.SIQ:测序数据中突变谱的简易定量测量。
NAR Genom Bioinform. 2022 Sep 5;4(3):lqac063. doi: 10.1093/nargab/lqac063. eCollection 2022 Sep.
9
Frequent aneuploidy in primary human T cells after CRISPR-Cas9 cleavage.CRISPR-Cas9 切割后原发性人 T 细胞中频繁的非整倍体。
Nat Biotechnol. 2022 Dec;40(12):1807-1813. doi: 10.1038/s41587-022-01377-0. Epub 2022 Jun 30.
10
Cas9-induced large deletions and small indels are controlled in a convergent fashion.Cas9 诱导的大片段缺失和小片段插入以收敛的方式被控制。
Nat Commun. 2022 Jun 14;13(1):3422. doi: 10.1038/s41467-022-30480-8.